FOLH1 and benign prostatic hyperplasia: Further, expression of PSMA has been shown to increase from benign prostate hyperplasia (BPH) to PCA and to correlate with Gleason score and disease aggressiveness, which implies a role for PSMA not only in proliferation, but also in tumor malignity [51,68,69,70].